MedTech M&As in 2025: A Roundup

MedTech M&As in 2025 featured an array of transactions — from acquisitions that bolster interventional systems and digital testing capabilities to strategic moves in manufacturing and specialized equipment — that underscore the sector’s commitment to advancing technology and operational excellence.

Stay tuned for Xtalks’ monthly updates on M&As across the MedTech sector, with the next installment covering March 2025, as we continue to track and analyze emerging trends in MedTech M&As.

This blog covers transformative deals in the medtech space — from device innovations to manufacturing enhancements — that are driving product excellence and expanding global capabilities.

Interventional Devices & Surgical Technology

• Aptyx – Medical Murray’s NC Facility: Aptyx expanded its interventional portfolio by acquiring Medical Murray’s North Carolina facility — specializing in catheter‐based interventional products and transcatheter implants — to support its next-generation system launch.
• KARL STORZ – T1V’s Medical Biz: KARL STORZ strengthened its global digital surgery suite by acquiring T1V’s medical business, which includes the CollaboratOR system exclusively sold since 2018, to integrate advanced hardware and software solutions.
• Boston Scientific – Bolt Medical: Boston Scientific enhanced its cardiovascular offerings by acquiring Bolt Medical, the pioneer of the intravascular lithotripsy concept developed in 2019, in a $664 million deal with milestone-based payments.
• Stryker – Inari Medical: Stryker fortified its innovation in vascular therapies by acquiring Inari Medical — whose non-thrombolytic clot removal solutions complement its neurovascular portfolio — in a transaction valued at roughly $4.9 billion.
• Tyber Medical, Intech & Resolve Surgical Technologies (Merger): Tyber Medical, Intech, and Resolve Surgical Technologies have merged to create a next-generation medtech solutions provider that unifies product development with enhanced after-sales service.
• Argon Medical Acquires SeQure and DraKon Microcatheters: Argon Medical broadened its oncology intervention portfolio by acquiring the SeQure and DraKon microcatheters, enabling precise therapeutic delivery in cancer treatments.
• Teleflex – Biotronik’s Vascular Intervention Unit: Teleflex, a leader in medical technology, will acquire Biotronik’s vascular intervention unit for approximately €760 million (roughly $823 million). This acquisition strengthens Teleflex’s interventional device portfolio and aims to enhance treatment outcomes in vascular procedures.​
• Boston Scientific – SoniVie Ltd: Boston Scientific expanded its interventional medical devices portfolio by acquiring SoniVie Ltd. The move integrates innovative technology that complements Boston Scientific’s existing interventional solutions, aiming to drive improvements in procedural outcomes.
• Medtronic – Nanovis Nano-Surface Implant Technology: Medtronic acquired nano-surface technology from Nanovis, a cutting-edge treatment that accelerates bone growth on spinal implants. By incorporating this innovation into its next-gen spinal fusion devices, Medtronic aims to address key challenges in spinal surgeries.​
• Globus Medical – Nevro: Globus Medical announced an all-cash acquisition of Nevro, a company specializing in spinal cord stimulation devices for chronic pain management. Valued at around $250 million, this deal emphasizes the growing focus on innovative pain management solutions.
• DeRoay Acquires Predictive Oncology Skyline Medical Assets: DeRoyal acquired the STREAMWAY system, a closed-loop surgical fluid management platform designed to reduce biohazard exposure and eliminate canister-based waste handling in ORs.
• Ostial Corporation Becomes Verge Medical: Ostial rebranded as Verge Medical after acquiring Wavella, a catheter-based rotational atherectomy platform designed for eccentric calcified lesions in peripheral and coronary arteries.
• Alcon – LENSAR, Inc.: Alcon announced plans to acquire LENSAR, adding the ALLY femtosecond laser and Streamline software, which integrate real-time imaging and energy modulation for cataract surgery.
• Globus Medical – Nevro Corp.: Globus Medical finalized its acquisition of Nevro Corp. in an all-cash transaction, adding spinal cord stimulation systems for pain management to its therapeutic offerings. The deal taps into a $2.5 billion opportunity within the broader musculoskeletal market — one that includes potential growth in neuromodulation and adjacent care areas.
• VB Spine – Stryker (US Spine Business): VB Spine LLC was formed by Viscogliosi Brothers to acquire Stryker’s US spine business. The acquisition includes access to technologies like Mako Spine and Copilot, allowing VB Spine to broaden its presence in spinal implants and procedure-enabling platforms.

Testing & Clinical Research

• NAMSA – US Medical Device Testing Operations: NAMSA has augmented its clinical research and testing capabilities by acquiring WuXi AppTec’s US operations in Minnesota and Georgia — its ninth acquisition since joining ARCHIMED — to enrich its service portfolio.

Materials & Manufacturing Solutions

• GEON Performance Solutions – Foster Corporation: GEON Performance Solutions diversified its offerings by acquiring Foster Corporation, a key supplier of high-performance biomedical polymers critical for medtech manufacturing.
• Intek Plastics – Five Star Plastics: Intek Plastics enhanced its production capabilities by acquiring Five Star Plastics, thereby expanding its suite of manufacturing services across the medical device sector.
• Gainline Capital Partners – M&M International: Gainline Capital Partners extended its operational scale by acquiring M&M International, a specialist in precision components that drives product innovation in medtech.
• Aspen Medical Products – Advanced Orthopaedics: Aspen Medical Products acquired Advanced Orthopaedics to extend its expertise beyond spine innovation and tap into the growing bracing and supports market. This move integrates Advanced Orthopaedics’ portfolio of bracing solutions and orthopedic soft goods, enhancing global reach and establishing a platform for rapid growth.​
• Integer – Precision Coating: Integer, a leading contract manufacturer in the medical device industry, announced the acquisition of Precision Coating. This acquisition enhances Integer’s capabilities in advanced coating technology, a key component in improving the performance and durability of implantable devices.
• Holdings – Surmodics Inc. (blocked by FTC): GTCR BC Holdings’ bid to acquire Surmodics Inc., a leader in hydrophilic coatings for medical devices, was blocked by the Federal Trade Commission (FTC) over antitrust concerns. The deal would have given GTCR control of over 50% of the outsourced coatings market, raising competition risks in a sector critical for implantable devices. This case is an example of the regulatory scrutiny on medtech consolidation, especially where market dominance may stifle innovation or drive up costs.
• SVP and Stellex – Exactech: Exactech, known for its Truliant and Vantage implant lines, was acquired by SVP and Stellex to support the continued development of its AI-powered Active Intelligence surgical planning suite.

Drug Delivery & Respiratory Technologies

• Phillips Medisize – Vectura: Phillips Medisize bolstered its drug delivery portfolio by acquiring Vectura, whose proprietary dry powder inhaler technology expands its respiratory therapy solutions.
• Eyenovia and Betaliq Enter Reverse Merger: Eyenovia and Betaliq plan to merge, combining Optejet piezo-print technology for microdosing with EyeSol, a water-free formulation platform targeting glaucoma and dry eye.
• ResMed – VirtuOx: ResMed acquired VirtuOx, a virtual diagnostic company specializing in sleep and respiratory testing. While financial terms were not disclosed, the acquisition is expected to support ResMed’s connected health strategy and enhance access to home-based diagnostic services.

Women’s Health

• Hologic – Gynesonics: Hologic expanded its women’s health portfolio by acquiring Gynesonics, thereby enhancing its intrauterine imaging and transcervical fibroid treatment capabilities to capture a greater market share.
• Caldera Medical – Ethicon’s GYNECARE TVT Family of Products: Caldera Medical expands its women’s health portfolio by acquiring Ethicon’s TVT family — gaining proven pelvic floor repair devices that address stress urinary incontinence and pelvic organ prolapse.

Wound Care

• RF Health – HeelP.O.D. Pressure Offloading Device: RF Health acquires the HeelP.O.D. device, which leverages advanced sensor technology to monitor and redistribute pressure, reducing pressure injury risks in clinical and long-term care settings.

Specialized Equipment & Manufacturing Solutions

• Danaher Cryogenics – ADR Cryostat Product Line: Danaher Cryogenics reinforced its sub-kelvin technology portfolio by acquiring the ADR Cryostat product line, expanding its reach within the specialized cryogenics market.

Diagnostics & Testing Services​

• Thermo Fisher Scientific – Solventum’s Filtration Business: Thermo Fisher Scientific plans to acquire Solventum’s purification and filtration business for roughly $4.1 billion. This division specializes in advanced filters and membranes used in both biologics production and medical device manufacturing, aiming to enhance both drug development and device safety.​
• Quest Diagnostics – Fresenius Medical Care’s Kidney Testing Assets: Quest Diagnostics agreed to acquire kidney testing assets from Fresenius Medical Care. Although financial details have not yet been disclosed, this move will bolster Quest Diagnostics’ capabilities in diagnostic testing, specifically for dialysis and kidney function.
• Advanced Instruments – Nova Biomedical: The merger combines Advanced Instruments’ osmolality and cell culture analyzers with Nova’s blood gas and glucose testing systems, creating a unified life sciences diagnostics platform.
• Firefly Neuroscience – Evoke Neuroscience: Firefly Neuroscience acquired Evoke Neuroscience for $6 million in a mix of cash and stock, with an additional $500,000 earn-out. The deal significantly increases Firefly’s EEG/ERP data assets, expands its IP portfolio and strengthens its commercial presence in cognitive assessment and brain health analytics.
• RadNet – iCAD: RadNet agreed to acquire iCAD in an all-stock deal valued at approximately $103 million, offering 0.0677 shares of RadNet for each iCAD share. The transaction brings iCAD’s AI-based mammography and oncology tools into RadNet’s DeepHealth platform, expanding its footprint in early cancer detection.

Digital Health & AI Advancements​

• MoveUp – Deep Structure AI: MoveUp revealed plans to acquire Deep Structure AI to strengthen its AI-driven orthopedic care solutions. This strategic move is designed to integrate advanced deep learning technology into MoveUp’s digital health platform, enhancing the precision and personalization of orthopedic treatment planning.​
• Surgimate – ImplantBase: Surgimate’s acquisition of ImplantBase expands its surgical coordination software suite by adding an inventory logistics and sales operations platform, enhancing workflow efficiencies for medical device manufacturers and distributors.
• electroCore – NeuroMetrix: electroCore completed its $9 million acquisition of NeuroMetrix, including $4.49 per share in cash and performance-based contingent value rights. The addition of the FDA-cleared Quell system supports electroCore’s focus on non-invasive therapies for chronic pain and fibromyalgia, particularly within the VA healthcare system.

If you want your company to be featured on Xtalks.com, please email [email protected].